Abstract
There is a subset of patients who have biochemical and histologic features consistent with primary biliary cirrhosis (PBC) who lack antimitochondrial antibodies (AMA). This entity is usually referred to as AMA-negative PBC or alternatively autoimmune cholangitis. Patients who have AMA-negative PBC are believed to have a similar clinical course, response to treatment, and prognosis as their AMA-positive counterparts. As more sensitive and specific serologic tests are developed to detect serum AMA, it is possible we may find that these patients initially believed to be AMA-negative are indeed AMA-positive, suggesting a single disease process.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 479-484 |
| Number of pages | 6 |
| Journal | Gastroenterology Clinics of North America |
| Volume | 37 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2008 |
| Externally published | Yes |
ASJC Scopus subject areas
- Gastroenterology
Fingerprint
Dive into the research topics of 'Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS